SPECIAL AT-RICH SEQUENCE BINDING PROTEIN 1 (SATB1) IS MARKEDLY EXPRESSED IN THE DARK ZONE GERMINAL CENTER B CELLS ON MURINE SPLEEN

EHA Library, Takayuki Ozawa, 266262

LARGE SCALE CULTURE AND DIFFERENTIATION OF ERYTHROBLASTS FROM PBMC

EHA Library, Marie-Jose Claessen, 266263

DEFERASIROX DRIVES ROS-MEDIATED DIFFERENTIATION AND INDUCES INTERFERON-STIMULATED GENES EXPRESSION IN HEALTHY HEMATOPOIETIC STEM/PROGENITOR CELLS AND IN LEUKEMIA CELLS

EHA Library, Tiziana Tataranni, 266264

UPREGULATION OF CD276 IN ENDOTHELIAL CELLS OF MURINE AND PDX ACUTE MYELOID LEUKAEMIA MODELS

EHA Library, Antoniana Batsivari, 266265

POTENTIAL COMBINATIONAL THERAPY OF LEUKEMIC STEM CELLS USING BONE MORPHOGENETIC PROTEIN AND TYROSINE KINASE INHIBITORS.

EHA Library, Caroline Busch, 266266

NEW MOLECULES INSPIRED ON MICROBIOTA METABOLITES TARGETING ACUTE MYELOID LEUKEMIA CELLS

EHA Library, Sergio Algar, 266267

PRIMARY THERAPY AND RELATIVE SURVIVAL IN CLASSIC HODGKIN LYMPHOMA: A NATIONWIDE POPULATION-BASED STUDY AMONG 9,367 ADULT PATIENTS DIAGNOSED IN THE NETHERLANDS FROM 1989 TO 2016

EHA Library, Julia Driessen, 266268

TISLELIZUMAB (BGB-A317) FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: UPDATED FOLLOW-UP EFFICACY AND SAFETY RESULTS FROM A PHASE 2 STUDY

EHA Library, Yuqin Song, 266269

FIVE-YEAR SURVIVAL AND DURABILITY RESULTS OF THE BEGEV REGIMEN FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA

EHA Library, Francesca RICCI, 266270

DEPRESSION AND ANXIETY IN HODGKIN LYMPHOMA SURVIVORS: A DANISH NATIONWIDE COHORT STUDY OF 896 PATIENTS

EHA Library, Andreas Øvlisen, 266271

VERY LATE REALAPSES (VLR) ≥5 YEARS AFTER INITIAL TREATMENT WITH CHEMOTHERAPY±RADIOTHERAPY (CT±RT) IN HODGKIN LYMPHOMA (HL): A JOIN STUDY ON TREATMENT STRATEGIES AND PROGNOSTIC FACTORS FOR THE OUTCOME

EHA Library, Theodoros Vassilakopoulos, 266272

PEDIATRIC HODGKIN LYMPHOMA: DISPARITIES IN SURVIVAL BY RACE

EHA Library, Karishma Khullar, 266273

RETROSPECTIVE REAL-LIFE STUDY OF BRENTUXIMAB VEDOTIN IN ASSOCIATION WITH BENDAMUSTINE IN REFRACTORY OR MULTIPLE RELAPSED HODGKIN LYMPHOMA.

EHA Library, Emilio iannitto, 266274

PROGNOSTIC VALUE OF METABOLIC TUMOR VOLUME AND TOTAL LESION GLYCOLYSIS CALCULATION ON BASELINE 18F-FDG-PET-CT IN PATIENTS WITH HODGKIN´S LYMPHOMA AND ITS CORRELATION WITH CLINICAL CHARACTERISTICS

EHA Library, Karla Bermúdez, 266275

SALVAGE OPTIONS FOR HD PATIENTS FAILING INITIAL ABVD TREATMENT

EHA Library, Oliver Karanfilski, 266276

CHANGES IN OVERALL SURVIVAL OF HODGKIN’S LYMPHOMA PATIENTS IN UKRAINIAN POPULATION DURING LAST DECADES

EHA Library, Kateryna Filonenko, 266277

DOES ESCALATED BEACOP-DACARBAZINE DO THE SAME AS ESCALATED BEACOP-PROCARBAZINE FOR UNFAVORABLE HODGKIN’S LYMPHOMA?

EHA Library, Raoudha Mansouri, 266278

CLINICAL AND BIOLOGICAL PREDICTORS OF OUTCOME IN LARGE GRANULAR LYMPHOCYTE LEUKEMIA: A SINGLE CENTER EXPERIENCE OF 205 PATIENTS.

EHA Library, Gregorio Barila', 266279

THE DUAL SYK/JAK INHIBITOR CERDULATINIB DEMONSTRATES RAPID AND DURABLE TUMOR RESPONSES IN A PHASE 2 STUDY IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA - AS A SINGLE AGENT AND COMBINED WITH RITUXIMAB

EHA Library, Paul A. Hamlin, 266280

UPDATED SAFETY AND EFFICACY DATA IN A PHASE 1/2 TRIAL OF PATIENTS WITH WALDENSTRÖM MACROGLOBULINAEMIA (WM) TREATED WITH THE BRUTON TYROSINE KINASE (BTK) INHIBITOR ZANUBRUTINIB (BGB-3111)

EHA Library, Judith Trotman, 266281

CLINICAL EFFICACY OF THE RIBVD REGIMEN FOR REFRACTORY/RELAPSED (R/R) MANTLE CELL LYMPHOMA (MCL) PATIENTS: A RETROSPECTIVE STUDY OF THE LYSA GROUP.

EHA Library, Caroline Regny, 266282

EFFICACY WAS IMPROVED WITH LENALIDOMIDE/RITUXIMAB (R2) VS RITUXIMAB/PLACEBO IN PATIENTS WITH FOLLICULAR LYMPHOMA IRRESPECTIVE OF POD24 STATUS IN THE PHASE III AUGMENT STUDY

EHA Library, John Leonard, 266283

MARKERS ASSOCIATED WITH SHORT SURVIVAL IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA

EHA Library, Gordon Ruan, 266284

PARTIAL RESPONSE OR BETTER AT 6 MONTHS IS PROGNOSTIC OF PROGRESSION-FREE SURVIVAL IN PATIENTS WITH WALDENSTROM MACROGLOBULINEMIA TREATED WITH IBRUTINIB

EHA Library, Jorge Castillo, 266285

THE IMPACT OF PRIOR MALIGNANCIES ON THE DEVELOPMENT OF SECOND MALIGNANCIES AND SURVIVAL IN PATIENTS WITH FOLLICULAR LYMPHOMA: A NATIONWIDE POPULATION-BASED STUDY IN THE NETHERLANDS

EHA Library, Manette Dinnessen, 266286

MAJOR RESPONSES IN MYD88 WILDTYPE (MYD88WT) WALDENSTRÖM MACROGLOBULINEMIA (WM) PATIENTS TREATED WITH BRUTON TYROSINE KINASE (BTK) INHIBITOR ZANUBRUTINIB (BGB-3111)

EHA Library, Meletios Dimopoulos, 266287

AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MANTLE CELL LYMPHOMA - OUTCOMES FROM A SINGLE ACADEMIC CENTRE

EHA Library, Michael Northend, 266288

BR VS RCHOP AS INITIAL TREATMENT FOR ADVANCED STAGE FOLLICULAR LYMPHOMA: A MATCHED-PAIR ANALYSIS

EHA Library, Paolo Strati, 266289

PRESENCE OF BRAFV600E MUTATION IN CHILDHOOD LCH CORRELATES WITH MULTISYSTEM DISEASE AND A POOR SURVIVAL

EHA Library, Prateek Bhatia, 266290

COLD AGGLUTININ DISEASE: A RETROSPECTIVE ANALYSIS OF 95 CASES

EHA Library, Pierre Daufresne, 266291

RESPONSE AND SURVIVAL OUTCOMES OF WALDENSTROM MACROGLOBULINEMIA PATIENTS ON IBRUTINIB THERAPY ON AND OFF CLINICAL TRIAL

EHA Library, Jorge Castillo, 266292

TP53 STATUS IN MANTLE CELL LYMPHOMA (MCL) - A 10 YEAR SINGLE CENTER EXPERIENCE

EHA Library, Ezzat Elhassadi, 266293

CLINICAL OUTCOMES WITH SINGLE-AGENT IBRUTINIB FOR RELAPSED/REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL): INTERIM ANALYSIS (IA) OF THE BELGIAN IBRUTINIB REAL-WORLD DATA (BIRD) STUDY

EHA Library, Ann Janssens, 266294

WHIMSICAL (WALDENSTRÖM’S MACROGLOBULINEMIA STUDY INVOLVING CART-WHEEL): A GLOBAL PATIENT-DERIVED DATA REGISTRY MAPPING TREATMENT AND QUALITY OF LIFE DATA

EHA Library, Ibrahim Tohidi-Esfahani, 266295

TREATMENT PATTERNS AMONG PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA

EHA Library, Sheila R. Reddy, 266296

INFLAMMATION-DRIVEN HEME/IRON CYTOTOXICITY IN PARKINSON’S DISEASE

EHA Library, Raffaella Gozzelino, 266297

A PHASE 2, RANDOMIZED, CONTROLLED, OPEN-LABEL TRIAL OF DAILY VERSUS ALTERNATE DAY ORAL IRON IN TREATMENT OF IRON DEFICIENCY ANEMIA

EHA Library, Deepesh Lad, 266298

COMPLIANCE AND CLINICAL BENEFIT OF DEFERASIROX GRANULE FORMULATION VS DISPERSIBLE TABLETS IN PEDIATRIC PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD: RESULTS FROM THE PHASE II CALYPSO STUDY

EHA Library, Ali Taher, 266299

A NEW FTL GENE MUTATION RESPONSIBLE FOR HYPOFERRITINEMIA WITHOUT IRON DEFICIENCY

EHA Library, Patricia Aguilar Martinez, 266300

HOMOZYGOUS I281T MUTATION IN HJV CAUSING INDOLENT JUVENILE HEMOCHROMATOSIS WITH A MIDDLE TO LATE ONSET

EHA Library, Akiyoshi Takami, 266301

A PROPOSAL OF AN ALGORITHM FOR THE DIAGNOSIS OF TYPE 1 GAUCHER DISEASE STARTING FROM HYPERFERRITINEMIA IN ADULTS

EHA Library, Giacomo Marchi, 266302

MIGRATION FLOWS, IRON DEFICIENCY AND ANAEMIA AMONG PREGNANT REFUGEES IN NORTHERN GREECE

EHA Library, DESPOINA ADAMIDOU, 266303

LONG-TERM SEQUENTIAL DEFERIPRONE AND DEFERASIROX THERAPY IN TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS: A PROSPECTIVE CLINICAL TRIAL

EHA Library, Aurelio Maggio, 266304

FIRST-IN-HUMAN SINGLE- AND MULTIPLE-ASCENDING DOSE STUDY OF THE ORAL FERROPORTIN INHIBITOR VIT-2763 IN HEALTHY SUBJECTS

EHA Library, Frank Richard, 266305

EVIDENCE FOR AN ALTERNATIVE MECHANISM SUPPRESSING HEPCIDIN DURING THE RECOVERY FROM HEMORRHAGE-INDUCED ANEMIA

EHA Library, Ugo Sardo, 266306

THE HEPCIDIN-ERYTHROFERRONE AXIS AND ITS RELATIONSHIP WITH ERYTHROPOIESIS IN DIFFERENT TYPES OF ANEMIA

EHA Library, Rafael Del Orbe Barreto, 266307

AUTOCHTHONOUS MOUSE MODELS OF MYD88 P.L265P - AND BCL2-DRIVEN DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Ruth Fluemann, 266308

MOLECULAR ANALYSIS OF PRIMARY CUTANEOUS DIFFUSE LARGE B-CELL LYMPHOMA LEG TYPE AT DIAGNOSIS AND RELAPSE - IMPLICATIONS FOR TARGETED THERAPIES

EHA Library, Anne Schrader, 266309

A 14-GENE SIGNATURE ASSOCIATED TO CHOLESTEROL METABOLISM IDENTIFIES M1-LIKE TUMOR-INFILTRATING MACROPHAGES AND PREDICTS PATIENT SURVIVAL IN DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Maria Carmela Vegliante, 266310

DISSECTING THE MOLECULAR PROFILES IN DIFFUSE LARGE B-CELL LYMPHOMA USING THE RNA- AND PROTEIN-BARCODED NCOUNTER METHOD

EHA Library, Chih-Cheng Chen*, 266311

NEXT-GENERATION SEQUENCING-BASED CLONALITY ASSESSMENT OF IMMUNOGLOBULIN GENE REARRANGEMENTS DISTINGUISHES RELAPSE FROM SECOND PRIMARY CLASSICAL HODGKIN LYMPHOMA

EHA Library, Blanca Scheijen, 266312

MUTATIONS AFFECTING THE CREBBP HAT DOMAIN PREDICT RESPONSE TO MTOR INHIBITORS EVEROLIMUS AND TEMSIROLIMUS IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA.

EHA Library, Emil Kumar, 266313

LOSS OF 18Q22.1-Q23 IS SIGNIFICANTLY ASSOCIATED WITH GCB-DLBCL AND FAILURE TO ACHIEVE EFS24

EHA Library, Kerstin Wenzl, 266314

A PHASE I STUDY OF THE BTK INHIBITOR ABIVERTINIB (AC0010) IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL LYMPHOMA

EHA Library, Min Yang, 266315

ESTROGEN BETA RECEPTOR: A NEW TARGET FOR DIFFUSE LARGE B-CELL LYMPHOMA.

EHA Library, Myra Langendonk, 266316

SOMATIC COPY NUMBER GAINS IN MYC, BCL2, OR BCL6, IN ADDITION TO TRANSLOCATIONS, IDENTIFIES A SUBSET OF AGGRESSIVE ALTERNATIVE-DH/TH DLBCL PATIENTS

EHA Library, Jordan Krull, 266318

MOLECULAR PROFILING OF PRIMARY BONE LYMPHOMA’S REVEALS FREQUENT MUTATIONS IN EZH2 AND OTHER EPIGENETIC GENES: IMPLICATIONS FOR TARGETED TREATMENT.

EHA Library, Ruben de Groen, 266319

C-REL NF-KAPPA B SUBUNIT ACTIVITY REFINES A DISTINCT GERMINAL CENTER DIFFUSE LARGE B-CELL LYMPHOMA SUBGROUP WITH FAVORABLE OUTCOME

EHA Library, Nathalie Faumont, 266320

CHOP TREATMENT ENHANCES DEPENDENCY ON BCL-2, MCL-1 AND BCL-XL IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Mathilde de Jong, 266321

MUTATIONAL LANDSCAPE OF PRIMARY MEDIASTINAL B-CELL LYMPHOMA (PMBCL) BY MEANS OF CIRCULATING TUMOR DNA ANALYSIS

EHA Library, Alfredo Rivas-Delgado, 266322

NOVEL THIENOPYRIDINE DERIVATIVES INDUCE TUBULIN DISRUPTION AND CAUSE CELL CYCLE ARREST IN MALIGNANT B-CELLS

EHA Library, Christopher Broughton, 266323

EVALUATION OF SERINE BIOSYNTHESIS PATHWAY AS A POTENTIAL THERAPEUTIC TARGET IN BURKITT LYMPHOMA

EHA Library, Emilia Bialopiotrowicz, 266324

SURVIVAL CONTINUES TO INCREASE IN DIFFUSE LARGE B-CELL LYMPHOMA: A POPULATION-BASED ANALYSIS AMONG 25,143 PATIENTS DIAGNOSED IN THE NETHERLANDS BETWEEN 1989 AND 2016

EHA Library, Mujde Durmaz, 266325

STRUCTURAL AND FUNCTIONAL VARIABILITY OF THE TUMOR B-CELL RECEPTOR INDICATES A ROLE FOR ENVIRONMENTAL INFLUENCES ON BEHAVIOR OF MANTLE CELL LYMPHOMAS

EHA Library, David Dutton, 266326

PROTEIN KINASE CK1 ALPHA INACTIVATION CAUSES MANTLE CELL LYMPHOMA GROWTH ARREST AND SYNERGISTICALLY ENHANCES IBRUTINIB CYTOTOXICITY

EHA Library, Sabrina Manni, 266327

INTEGRATING DETECTION OF COPY NEUTRAL CHROMOSOMAL LOSSES IN A CLINICAL SETTING IN LEUKEMIA AND LYMPHOMA BY MEANS OF ALLELIC IMBALANCE AND READ DEPTH RATIO COMPARISON

EHA Library, Marcus C. Hansen, 266328

PROGNOSTIC CORRELATION OF CELL-OF-ORIGIN AND MYC, BCL-2 AND BCL-6 STATUS IN HIV-ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMAS

EHA Library, Lara Crucitti, 266329

CORRELATION OF CD10 EXPRESSION DETERMINED BY FLOW CYTOMETRIC IMMUNOPHENOTYPING AND CELL-OF-ORIGIN DETERMINATION BY GENE EXPRESSION PROFILING IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Ryan S. Robetorye, 266330

TRANSFORMING ACTIVITIES OF THE NUP98-KMT2A FUSION GENE ASSOCIATED WITH MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA

EHA Library, J Neil Fisher, 266331

INTEGRATED PROFILING OF DNA METHYLATION AND MUTATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES.

EHA Library, Suguru Morimoto, 266332

MUTATIONS ON COHESIN COMPLEX ARE ASSOCIATED TO A POOR PROGNOSIS IN LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS

EHA Library, Marta Martín Izquierdo, 266333

COPY NUMBER VARIATIONS AND UNIPARENTAL DISOMY PREDICT POOR SURVIVAL IN PATIENTS WITH IDIOPATHIC CYTOPENIA OF UNDETERMINED SIGNIFICANCE AND ARE ASSOCIATED WITH MACROCYTOSIS

EHA Library, Stine Ulrik Mikkelsen, 266334

CLINICAL AND MOLECULAR CHARACTERISTICS OF SRSF2-MUTATED NEOPLASMS.

EHA Library, GABRIELE TODISCO, 266335

THE EFFECT OF 5-AZACITIDINE TREATMENT ON THE OF BONE MARROW MESENCHYMAL STEM TRANSCRIPTOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

EHA Library, Ioannis Liapis, 266336

THE STAT SIGNALING BIOSIGNATURE OF CD4+ T CELL SUBSETS REFLECT THE IMMUNOGENICITY OF HIGH-RISK MDS AND PREDICT AZACYTIDINE TREATMENT OUTCOME

EHA Library, Zoi Bezirgiannidou, 266337

GENETIC EVOLUTION PATTERNS IN PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA TO SECONDARY ACUTE MYELOID LEUKEMIA: AN ANALYSIS OF 36 PAIRED SAMPLES

EHA Library, Yi Jiun Su, 266338

MIR-223 IS SUPPRESSED IN EXOSOMES OF PATIENTS WITH HIGH-RISK MYELODYSPLASTIC SYNDROMES AND MAY BE A MARKER OF RESIDUAL GRANULOCYTIC-MONOCYTIC DIFFERENTIATION

EHA Library, Bruno Benites, 266339

TERT PROMOTER METHYLATION AS A POTENTIAL PROGNOSTIC BIOMARKER FOR PROGRESSION OF UNEXPLAINED CYTOPENIA TO MDS AND AML

EHA Library, Katja Kaastrup, 266340

TRANSCRIPTIONAL ALTERATIONS OF HEMATOPOIETIC STEM CELLS IN MYELODYSPLASTIC SYNDROMES

EHA Library, Teresa Ezponda, 266341

MITOCHONDRIAL GENOMIC ANALYSIS IN PATIENTS WITH MYELOID MALIGNANCIES

EHA Library, Seon Young Kim, 266342

PROMOTER METHYLATION OF TUMOR SUPPRESSOR GENES ON THE SHORT ARM OF CHROMOSOME 1 IN MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA

EHA Library, Naoki Mori, 266343

THE DIFFERENT MUTATIONAL LANDSCAPES OF A PANEL GENES BY NEXT GENERATION SEQUENCING IN 967 CASES OF MDS AND AML

EHA Library, Yanfang Liu, 266344

EASIX FOR PREDICTION OF SURVIVAL IN LOWER RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Almuth Merz, 266345

THE SFGM-TC MDS SCORE AT DAY 180 IS ASSOCIATED WITH POST-TRANSPLANT OUTCOMES IN PATIENTS WITH MYELODYSPLASTIC SYNDROME WHO UNDERWENT CD34+ SELECTED ALLOGENEIC STEM CELL TRANSPLANT

EHA Library, Ana Alarcon, 266346

FACTORS ASSOCIATED WITH THE NEED FOR TRANSFUSIONS IN PATIENTS WITH LOWER RISK MYELODYSPLASTIC SYNDROME (MDS). DATA FROM THE REGULAR CARE MDS-REGISTRY IN GERMANY

EHA Library, H Tilman Steinmetz, 266347

PROGNOSTIC MUTATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME TREATED WITH HEMATOPOIETIC STEM-CELL TRANSPLANTATION

EHA Library, Zixian Liu, 266348

AUTOIMMUNE AND INFLAMMATORY DISEASES ASSOCIATE TO R-IPSS SCORE BUT NOT TO OVERALL SURVIVAL OR LEUKEMIC EVOLUTION IN MYELODYSPLASTIC SYNDROMES

EHA Library, Thomas Brunet, 266349

AZACITIDINE (VIDAZA®) IN PEDIATRIC PATIENTS WITH RELAPSED ADVANCED MDS: RESULTS OF A PHASE I/II STUDY BY THE ITCC CONSORTIUM AND THE EWOG-MDS GROUP: STUDY ITCC-015

EHA Library, Natasha van Eijkelenburg, 266350

CD10 EXPRESSION ON MYELOID PRECURSOR CELLS (CD34 + CD117 +) AS A PREDICTIVE FACTOR FOR PROGRESSION OF PRIMARY MYELODISPLASTIC SYNDROMES

EHA Library, Natalia Milanovich, 266351

PATIENT-REPORTED OUTCOME MEASURES IN CLINICAL STUDIES FOR MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA: A LITERATURE REVIEW AND LANDSCAPE ANALYSIS

EHA Library, Reinhard Stauder, 266352

CLONES WITH COMPLEX ABERRATIONS AND TP53 MUTATIONS RESPOND TO AZACITIDINE IN MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA

EHA Library, Christina Ganster, 266353

A GENOME-WIDE CRISPR SCREEN IDENTIFIES TOP2B AS AN ACQUIRED DRUGGABLE VULNERABILITY IN THE CONTEXT OF IMID RESISTANCE

EHA Library, Matteo Costacurta, 266354

PROGNOSTIC VALUE OF NEXT GENERATION FLOW MONITORING CIRCULATING TUMOR PLASMA CELLS IN PERIPHERAL BLOOD ON MYELOMA PATIENTS AFTER TREATMENT

EHA Library, Luzalba Sanoja-Flores, 266355

PRECLINICAL EVALUATION OF THE NEW GPRC5DXCD3 (JNJ-7564) BISPECIFIC ANTIBODY FOR THE TREATMENT OF MULTIPLE MYELOMA

EHA Library, Christie Verkleij, 266356

THE ANTI-BCMA ANTIBODY-DRUG CONJUGATE GSK2857916 DRIVES IMMUNOGENIC CELL DEATH AND IMMUNE-MEDIATED ANTI-TUMOR RESPONSES, AND IN COMBINATION WITH AN OX40 AGONIST POTENTIATES IN VIVO ACTIVITY

EHA Library, Rocio Montes de Oca, 266357

IBERDOMIDE (CC-220) IS PHARMACODYNAMICALLY ACTIVE AND HAS DOSE-DEPENDENT IMMUNOSTIMULATORY ACTIVITY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS IRRESPECTIVE OF PRIOR IMID DRUG TREATMENT

EHA Library, Michael Amatangelo, 266358

A MATURATION INDEX DEFINES NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH ADVANCED IMMUNOPHENOTYPIC AND MOLECULAR DIFFERENTIATION PROFILES ASSOCIATED WITH POOR PROGNOSIS

EHA Library, Marina Martello, 266359

DUAL-TARGETING OF PROMOTER AND ENHANCER DRIVEN PROCESSES SUPPRESSES MYELOMA CELL GROWTH AND VIABILITY VIA PERTURBATION OF THE MYELOMA PROLIFERATIVE PROGRAM.

EHA Library, Mariateresa Fulciniti, 266360

BLOCKING OF WIP1 PHOSPHATASE OVERCOMES BORTEZOMIB RESISTANCE AND PROMOTES CELL DEATH VIA ER STRESS-INDUCED APOPTOTIC JNK/C-JUN SIGNALING: NOVEL THERAPEUTIC TARGET IN MULTIPLE MYELOMA

EHA Library, Katia Beider, 266361

MARROW INFILTRATING T-REGULATORY CELLS ASSOCIATE WITH PD-1 EXPRESSING CD4 EFFECTOR CELLS AND INFERIOR OUTCOMES IN PATIENTS UNDERGOING NOVEL-AGENT REGIMENS FOR NEWLY DIAGNOSED MULTIPLE MYELOMA (MM)

EHA Library, Nouf Alrasheed, 266362